Abstract
We evaluated a 9-amino-acid peptide, SALLRSIPA (SAL), an agonist of activity-dependent neurotrophic factor (ADNF), for its protective properties against fetal alcohol-related brain growth retardation, using an established liquid diet model of alcohol-related neurodevelopmental disorder (ARND) in C57BL/6 mice. Alcohol exposure during neurulation reduced body weight, head size, and specifically brain weight and volume. Major gross brain deficits include underdevelopment of brain areas, cortical thinning, ventricle enlargement, and restricted midline neural tissue growth leading to openings at the roof/floor plate. SALLRSIPA (SAL) treatment increased fetal body weight and restored brain weight, brain volume, and regional brain size. Furthermore, SAL restored cortical thickness, reduced the size and frequency of neural tube openings, and attenuated ventricular enlargement. The ability of SAL to antagonize alcohol-retarded brain growth and development of forebrain and midline neural tube at midgestation suggests its potential use as an antagonist against fetal alcohol-rendered microencephaly early in development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aase J. M., Jones K. L., and Clarren S. K. (1995) Do we need the term “FAE”? Pediatrics 95, 428–430.
Abel E. L. (1984) Fetal Alcohol Syndrome and Fetal Alcohol Effect, Plenum Publishing, New York.
Becker H. C., Diaz-Granados J. L., and Randall C. L. (1996) Teratogenic actions of ethanol in the mouse: a minireview. Pharmacol. Biochem. Behav. 55, 501–513.
Brenneman D. E. and Gozes I. (1996) A femtomolaracting neuroprotective peptide. J. Clin. Invest. 97, 2299–2307.
Brenneman D. E., Hauser J., Neale E., Rubinraut S., Fridkin M., Davidson A., and Gozes I. (1998) Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J. Pharmacol. Exp. Ther. 285, 619–627.
Brenneman D. E., Phillips T. M., Festoff B. W., and Gozes I. (1997) Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann. N. Y. Acad. Sci. 814, 167–173.
Ericson J., Muhr J., Jessell T. M., and Edlund T. (1995) Sonic hedgehog: a common signal for ventral patterning along the rostrocaudal axis of the neural tube. Int. J. Dev. Biol. 39, 809–816.
Glazner G. W., Boland A., Dresse A. E., Brenneman D. E., Gozes I., and Mattson M. P. (1999) Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death. J. Neurochem. 73, 2341–2347.
Glazner G. W., Camandola S., and Mattson M. P. (2000) Nuclear factor-kappaB mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9. J. Neurochem. 75, 101–108.
Goodlett C. R. and Horn K. H. (2001) Mechanisms of alcohol-induced damage to the developing nervous system. Alcohol Res. Health 25, 175–184.
Gozes I. and Brenneman D. E. (1996) Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin? J. Mol. Neurosci. 7, 235–244.
Gozes I., Davidson A., Gozes Y., Mascolo R., Barth R., Warren D., et al. (1997) Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity. Brain Res. Dev. Brain Res. 99, 167–175.
Gozes I., Giladi E., Pinhasov A., Bardea A., and Brenneman D. E. (2000) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J. Pharmacol. Exp. Ther. 293, 1091–1098.
Gressens P., Marret S., Bodenant C., Schwendimann L., and Evrard P. (1999) Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity. J. Mol. Neurosci. 13, 199–210.
Gressens P., Marret S., Hill J. M., Brenneman D. E., Gozes I., Fridkin M., and Evrard P. (1997) Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J. Clin. Invest. 100, 390–397.
Middaugh L. D., Randall C. L. and Favara J. P. (1988) Prenatal ethanol exposure in C57 mice: effects on pregnancy and offspring development. Neurotoxicol. Teratol. 10, 175–180.
Middaugh L. D. and Baggan W. O. (1995) Prenatal maternal ethanol effects on pregnant mice and on off-spring viability and growth: influences of exposure time and weaning diet. Alcohol. Clin. Exp. Res. 19(5), 1351–1358.
Olney J. W., Tenkova T., Dikranian K., Muglia L. J., Jermakowicz W. J., D’Sa C. and Roth K. A. (2002) Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol. Dis. 9, 205–219.
Pinhasov A., Mandel S., Torchinsky A., Giladi E., Pittel Z., Goldsweig A. M., et al. (2003) Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res. Dev. Brain Res. 144, 83–90.
Rubenstein J. L. (1998) Development of serotonergic neurons and their projections. Biol. Psychiatry 44, 145–150.
Spong C. Y., Abebe D. T., Gozes I., Brenneman D. E., and Hill J. M. (2001) Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 297, 774–779.
Stratton K., Howe C., and Battaglia F. (1996) Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment, National Academy Press, Washington, D.C.
Sulik K. K., Cook C. S., and Webster W. S. (1988) Teratogens and craniofacial malformations: relationships to cell death. Development 103(Suppl.), 213–231.
Webster W. S. and Ritchie H. E. (1991) Teratogenic effects of alcohol and isotretinoin on craniofacial development: an analysis of animal models. J. Craniofac. Genet. Dev. Biol. 11, 296–302.
Webster W. S., Walsh D. A., McEwen S. E., and Lipson A. H. (1983) Some teratogenic properties of ethanol and acetaldehyde in C57BL/6J mice: implications for the study of the fetal alcohol syndrome. Teratology 27, 231–243.
Wilkemeyer M., L., Chen S. Y., Menkari C. E., Brenneman D. E., Sulik K. K., and Charness M. E. (2003) Differential effects of ethanol antagonism an neuroprotection in napvsipq prevention of ethanol-induced developmental toxicity. Proc. Natl. Acad. Sci. USA, 100, 8543–8548.
Wilkemeyer M. F., Menkari C. E., Spong C. Y., and Charness M. E. (2002) Peptide antagonists of ethanol inhibition of 11-mediated cell-cell adhesion. J. Pharmacol. Exp. Ther. 303, 110–116.
Ye W., Shimamura K., Rubenstein J. L., Hynes M. A., and Rosenthal A. (1998) FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93, 755–766.
Zamostiano R., Pinhasov A., Bassan M., Perl O., Steingart R. A., Atlas R., et al. (1999) A femtomolaracting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism. Neurosci. Lett. 264, 9–12.
Zhou F. C., Sari Y., Powrozek T., Goodlett C. R., and Li T.-K. (2003) Moderate alcohol exposure compromises neural tube midline development in prenatal brain. Dev. Brain Res. 144, 43–55.
Zhou F. C., Sari Y., and Zhang J. K. (2000) Expression of serotonin transporter protein in developing rat brain. Brain Res. Dev. Brain Res. 119, 33–45.
Zhou F. C., Sari Y., Li T. K., Goodlett G., Azmitia E. C. (2002) Deviations in brain early serotonergic development as a result of fetal alcohol exposure. Neurotox. Res. 4, 337–342.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, F.C., Sari, Y., Powrozek, T.A. et al. A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth. J Mol Neurosci 24, 189–199 (2004). https://doi.org/10.1385/JMN:24:2:189
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:24:2:189